BRPI0812403B8 - composição compreendendo proteína que carrega oxigênio baseada em porfirina modificada e uso da referida composição - Google Patents
composição compreendendo proteína que carrega oxigênio baseada em porfirina modificada e uso da referida composiçãoInfo
- Publication number
- BRPI0812403B8 BRPI0812403B8 BRPI0812403A BRPI0812403A BRPI0812403B8 BR PI0812403 B8 BRPI0812403 B8 BR PI0812403B8 BR PI0812403 A BRPI0812403 A BR PI0812403A BR PI0812403 A BRPI0812403 A BR PI0812403A BR PI0812403 B8 BRPI0812403 B8 BR PI0812403B8
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- oxygen
- protein based
- modified
- carrying protein
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 150000004032 porphyrins Chemical class 0.000 title abstract 2
- 230000037361 pathway Effects 0.000 abstract 2
- 102000001554 Hemoglobins Human genes 0.000 abstract 1
- 108010054147 Hemoglobins Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 102000018146 globin Human genes 0.000 abstract 1
- 108060003196 globin Proteins 0.000 abstract 1
- 150000003278 haem Chemical class 0.000 abstract 1
- -1 hemoglobin Chemical class 0.000 abstract 1
- SGGMZBKLQLBBLK-UHFFFAOYSA-N iron(4+) Chemical compound [Fe+4] SGGMZBKLQLBBLK-UHFFFAOYSA-N 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000027756 respiratory electron transport chain Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6445—Haemoglobin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0712685.7A GB0712685D0 (en) | 2007-06-29 | 2007-06-29 | Improvements relating to oxygen-carrying proteins (2) |
| PCT/GB2008/002199 WO2009004309A1 (en) | 2007-06-29 | 2008-06-26 | Modified globin proteins with altered electron transport pathway |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0812403A2 BRPI0812403A2 (pt) | 2014-12-02 |
| BRPI0812403B1 BRPI0812403B1 (pt) | 2019-08-27 |
| BRPI0812403B8 true BRPI0812403B8 (pt) | 2021-05-25 |
Family
ID=38420974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0812403A BRPI0812403B8 (pt) | 2007-06-29 | 2008-06-26 | composição compreendendo proteína que carrega oxigênio baseada em porfirina modificada e uso da referida composição |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8609814B2 (enExample) |
| EP (1) | EP2170948B1 (enExample) |
| JP (1) | JP2010531659A (enExample) |
| CN (1) | CN101711255A (enExample) |
| AU (1) | AU2008272721B2 (enExample) |
| BR (1) | BRPI0812403B8 (enExample) |
| CA (1) | CA2690370A1 (enExample) |
| GB (1) | GB0712685D0 (enExample) |
| WO (1) | WO2009004309A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2858495A4 (en) | 2012-04-30 | 2016-06-01 | Dow Agrosciences Llc | VEHICLES FOR RELEASING PESTICIDE COMPOSITIONS |
| GB201704006D0 (en) * | 2017-03-13 | 2017-04-26 | Univ Essex | Modified globin proteins |
| JP7387597B2 (ja) | 2017-07-18 | 2023-11-28 | ヴァーテック・バイオ・インコーポレイテッド | ヘモグロビンを含む代用血液及び作製方法 |
| GB201721503D0 (en) * | 2017-12-20 | 2018-01-31 | Univ Essex | Modified globin proteins |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8711614D0 (en) * | 1987-05-16 | 1987-06-24 | Medical Res Council | Proteins |
| US5884323A (en) * | 1995-10-13 | 1999-03-16 | 3Com Corporation | Extendible method and apparatus for synchronizing files on two different computer systems |
| EP0859789A1 (en) | 1995-10-23 | 1998-08-26 | Rice University | Hemoglobin mutants that reduce heme loss |
| GB0712683D0 (en) | 2007-06-29 | 2007-08-08 | Wivenhoe Technology Ltd | Improvements relating to oxygen-carrying proteins(1) |
-
2007
- 2007-06-29 GB GBGB0712685.7A patent/GB0712685D0/en not_active Ceased
-
2008
- 2008-06-26 AU AU2008272721A patent/AU2008272721B2/en active Active
- 2008-06-26 WO PCT/GB2008/002199 patent/WO2009004309A1/en not_active Ceased
- 2008-06-26 JP JP2010514108A patent/JP2010531659A/ja active Pending
- 2008-06-26 US US12/452,075 patent/US8609814B2/en active Active
- 2008-06-26 CN CN200880021531A patent/CN101711255A/zh active Pending
- 2008-06-26 BR BRPI0812403A patent/BRPI0812403B8/pt active IP Right Grant
- 2008-06-26 EP EP08775775.3A patent/EP2170948B1/en active Active
- 2008-06-26 CA CA2690370A patent/CA2690370A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2170948A1 (en) | 2010-04-07 |
| WO2009004309A1 (en) | 2009-01-08 |
| CA2690370A1 (en) | 2009-01-08 |
| AU2008272721A1 (en) | 2009-01-08 |
| US8609814B2 (en) | 2013-12-17 |
| BRPI0812403A2 (pt) | 2014-12-02 |
| GB0712685D0 (en) | 2007-08-08 |
| JP2010531659A (ja) | 2010-09-30 |
| CN101711255A (zh) | 2010-05-19 |
| AU2008272721B2 (en) | 2013-06-27 |
| BRPI0812403B1 (pt) | 2019-08-27 |
| EP2170948B1 (en) | 2016-11-02 |
| US20100137189A1 (en) | 2010-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR057614A1 (es) | Composiciones y metodos para producir moleculas de union con antigeno hibridas y usos de las mismas | |
| BR112012033295A2 (pt) | polipeptídeos curtos e contendo d-aminoácido para conjugados terapêuticos e seu uso | |
| BRPI0620806B8 (pt) | complexo e composição compreendendo um peptídeo e uma molécula carga, e uso da referida composição | |
| BRPI0514340A (pt) | formulações de estabilização | |
| BRPI0415480A (pt) | composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia | |
| BRPI0409911A (pt) | método para liberar uma molécula em uma célula, e, complexo carreador | |
| MX2009010777A (es) | Composiciones de carne que comprenden productos de proteina estructurada con color. | |
| TR201809514T4 (tr) | Uzun süre etkili insülin formülasyonları. | |
| ECSP088962A (es) | Nuevos herbicidas | |
| MX2009010935A (es) | Composiciones de alimentos secos. | |
| ATE517922T1 (de) | Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation | |
| NO20033941L (no) | Sammensetning som forbedrer aldersrelaterte fysiologiske mangler som forlenger levetiden | |
| ATE427948T1 (de) | Folat-mimetika und deren folatrezeptorbindende konjugate | |
| BRPI0812403B8 (pt) | composição compreendendo proteína que carrega oxigênio baseada em porfirina modificada e uso da referida composição | |
| BRPI0416544A (pt) | proteìna de ligação de gag | |
| BR112012027427A2 (pt) | composições nutritivas e métodos para a mudança da nutrição parenteral para a nutrição enteral | |
| BRPI0610786B8 (pt) | uso de um ou mais oligossacarídeos ácidos e neutros, e cisteína e/ou fonte de cisteína, e, composição alimentícia | |
| MX2009002787A (es) | Composiciones y métodos para prevenir el cáncer con cupredoxinas. | |
| BRPI0514411B8 (pt) | formulação, e, método de produzir uma formulação | |
| MX2008004734A (es) | Composicion rica en leucina. | |
| BRPI0707488B8 (pt) | método para a produção de uma composição de epoprostenol, composição farmacêutica e solução estável | |
| BRPI0511067A (pt) | processo para a formulação de formas de dosagem de dispersão rápida compreendendo pelo menos uma gelatina de peixe selecionada com base no peso molecular | |
| CY1115938T1 (el) | Νεα συνθεση για αυξηση της bio-διαθεσιμοτητας της νεουρτουρινης (neurturin) | |
| AR051765A1 (es) | Compuestos de moleculas conjugadas con una actividad reforzada de absorcion de celulas | |
| MY169785A (en) | Blood substitute with oxygen transport function, pharmaceutical composition (options) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B25D | Requested change of name of applicant approved |
Owner name: UNIVERSITY OF ESSEX ENTERPRISES LIMITED (GB) |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/08/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/08/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/06/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |